3 citations
,
May 2025 in “Lasers in Surgery and Medicine” Microneedle radiofrequency helps skin repair and rejuvenate by activating fibroblasts and remodeling the skin's structure.
Isotretinoin effectively improved severe pityriasis rubra pilaris with complications.
5 citations
,
June 2019 in “JAAD Case Reports” Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.
198 citations
,
September 2007 in “Clinics in Dermatology” Radiofrequency devices effectively tighten skin without surgery.
May 2023 in “Reactions Weekly” January 2013 in “Reactions Weekly” January 2019 in “Revista Dermatológica Centro Uraga” Alopecia triangular temporal is a rare condition with unclear causes and treatment, but trichoscopy helps in diagnosis.
January 1980 in “Archives of Dermatology” "Telogen defluxion" is a better term for hair loss than "telogen effluvium."
1 citations
,
July 2024 in “Journal of Investigative Dermatology” VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.
4 citations
,
January 2010 in “International journal of trichology” Bexarotene gel shows promise as a new treatment for alopecia areata.
5 citations
,
December 2019 in “JAAD Case Reports” A woman experienced rapid hair loss after taking albendazole, but it started to improve when she stopped the medication.
8 citations
,
January 2017 in “Korean Journal of Physiology and Pharmacology” Pimecrolimus boosts melanin production and movement of skin pigment cells.
November 2025 in “Contribuciones a las Ciencias Sociales” PRP is a safe and versatile treatment option, but more standardized clinical trials are needed to confirm its effectiveness.
November 2024 in “Huisarts en Wetenschap” Telogen effluvium hair loss often resolves on its own in 3 to 6 months, but see a dermatologist if it persists.
2 citations
,
January 2019 in “International Journal of Medicine in Developing Countries” Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.
12 citations
,
October 2013 in “British Journal of Dermatology” The meeting concluded with optimism about increasing research and better management of vitiligo.
April 2016 in “Journal of the American Academy of Dermatology” Treatment improved some symptoms but not all.
16 citations
,
March 2023 in “Gels” Paeonol-loaded gels may help reduce inflammation and skin damage in atopic dermatitis.
56 citations
,
August 2019 in “Clinical, Cosmetic and Investigational Dermatology” The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.
December 2023 in “Polish Journal of Chemical Technology” Ajuga reptans extracts can improve skin hydration, elasticity, and reduce wrinkles.
May 2025 in “Reactions Weekly” 2 citations
,
September 2024 in “Journal of the American Academy of Dermatology” Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.
November 2021 in “CRC Press eBooks” Anagen effluvium is a reversible condition causing sudden hair loss, often due to chemotherapy or head radiation.
38 citations
,
June 2019 in “International Journal of Molecular Sciences” Tiny particles called extracellular vesicles could help with skin healing and hair growth, but more research is needed.
1 citations
,
January 2017 in “International journal of trichology” Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.
1 citations
,
December 2025 in “Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)” Spanlastics effectively deliver Rizatriptan Benzoate with high efficiency and controlled release.
February 2026 in “Indian Journal of Skin Allergy” Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.
July 2023 in “AESTHETIC OROFACIAL SCIENCE” PDO threads improve skin firmness and elasticity with minimal recovery time.
GV-350 improves hair growth and quality of life in iron-deficient women without side effects.
1 citations
,
January 2009 in “Elsevier eBooks”